Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative hyperfractionated IMRT plus weekly cisplatin in high‑risk head and neck squamous cell carcinoma
jRCTs051210100Phase 2Completed
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cisplatin in head and neck squamous cell carcinoma (HNSCC). Primary endpoint: Completion rate of treatment. Started Oct 2021; status: completed.
02
Drugs
cisplatin
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on jRCTs051210100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051210100.